BC Innovations | Sep 8, 2011
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cutaneous T cell lymphoma (CTCL) MicroRNA-155 (miR-155); miR-203; miR-205 Studies in patient samples suggest differential expression of miRNAs could help diagnose CTCL. Microarray and PCR...
BC Innovations | Jun 26, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/ marker/pathway Summary Licensing status Publication and contact information Cancer Leukemia; lymphoma Abl1; Bcr-Abl1 tyrosine kinase; microRNA-203 A study suggests that expression of miRNA-203 may be useful for treating Abl1-positive...
Items per page:
1 - 2 of 2